Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Milner

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Circulation|September 10, 2009
The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillationDavid J Ellis, Mohammed Haris Usman, Peter G Milner, et al.
Plants (Basel, Switzerland)|December 1, 2020
Dissecting the Genetic Basis of Lateral and Central Spikelet Development and Grain Traits in <i>Intermedium</i>-Spike Barley (<i>Hordeum vulgare</i> Convar. <i>Intermedium</i>)Helmy M Youssef, Mohamed Allam, Faiza Boussora, et al.
Bioconjugate Chemistry|July 18, 2000
Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo durationD L Holmes, K Thibaudeau, B L'Archevêque, et al.
Applied and Environmental Microbiology|May 26, 2001
Kinetics of perchlorate- and chlorate-respiring bacteriaB E Logan, H Zhang, P Mulvaney, et al.
Thrombosis and Haemostasis|February 10, 2017
Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulantDetlef Albrecht, David Ellis, Daniel M Canafax, et al.
Journal of Cellular Physiology. Supplement|January 1, 1987
Platelet-derived growth factor/sis in normal and neoplastic cell growthT F Deuel, G F Pierce, H J Yeh, et al.
The Journal of Clinical Investigation|June 1, 1988
Endothelium-dependent relaxation is independent of arachidonic acid releaseP G Milner, N J Izzo, J Saye, et al.
Journal of Clinical Pharmacology|July 13, 2010
Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participantsLinda M Bavisotto, David J Ellis, Peter G Milner, et al.
Oncogene Research|February 1, 1988
Identification and purification of PDGF/sis-like proteins from nuclei of simian sarcoma virus-transformed fibroblastsG F Pierce, L K Shawver, P G Milner, et al.
Biochemical and Biophysical Research Communications|December 29, 1989
A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequenceP G Milner, Y S Li, R M Hoffman, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Circulation|September 10, 2009
The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillationDavid J Ellis, Mohammed Haris Usman, Peter G Milner, et al.
Plants (Basel, Switzerland)|December 1, 2020
Dissecting the Genetic Basis of Lateral and Central Spikelet Development and Grain Traits in <i>Intermedium</i>-Spike Barley (<i>Hordeum vulgare</i> Convar. <i>Intermedium</i>)Helmy M Youssef, Mohamed Allam, Faiza Boussora, et al.
Bioconjugate Chemistry|July 18, 2000
Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo durationD L Holmes, K Thibaudeau, B L'Archevêque, et al.
Applied and Environmental Microbiology|May 26, 2001
Kinetics of perchlorate- and chlorate-respiring bacteriaB E Logan, H Zhang, P Mulvaney, et al.
Thrombosis and Haemostasis|February 10, 2017
Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulantDetlef Albrecht, David Ellis, Daniel M Canafax, et al.
Journal of Cellular Physiology. Supplement|January 1, 1987
Platelet-derived growth factor/sis in normal and neoplastic cell growthT F Deuel, G F Pierce, H J Yeh, et al.
The Journal of Clinical Investigation|June 1, 1988
Endothelium-dependent relaxation is independent of arachidonic acid releaseP G Milner, N J Izzo, J Saye, et al.
Journal of Clinical Pharmacology|July 13, 2010
Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participantsLinda M Bavisotto, David J Ellis, Peter G Milner, et al.
Oncogene Research|February 1, 1988
Identification and purification of PDGF/sis-like proteins from nuclei of simian sarcoma virus-transformed fibroblastsG F Pierce, L K Shawver, P G Milner, et al.
Biochemical and Biophysical Research Communications|December 29, 1989
A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequenceP G Milner, Y S Li, R M Hoffman, et al.
Pageof 10